DYNAMIC III
07 Dec 2020
Trial Summary
Circulating tumour DNA (ctDNA) analysis informing adjuvant chemotherapy in stage III in colon cancer: A multicentre phase II/III randomised controlled trial
Acronym:
DYNAMIC III
ACTRN/NCT /ethics:
ACTRN12617001566325
Scientific title:
Circulating tumour DNA (ctDNA) analysis informing adjuvant chemotherapy in stage III in colon cancer: A multicentre phase II/III randomised controlled trial
Sponsor / Cooperative group:
–
Trial & Patient Characteristics
| Cancer Type | Bowel and colon |
|---|---|
| Trial Type | Treatment |
| Phase | Phase II, Phase III |
| Age Range | 18 years and older |
| Sex | All |
| Tumour Stream | - |
| Cancer Stage | Locally Recurrent or Locally Advanced |
| Anticipated Start Date | 2022-04-19 |
| Anticipated End Date | 2024-04-19 |
Participating Hospitals
| Hospital | The Queen Elizabeth Hospital |
|---|---|
| Clinical Trial Coordinator | Pamela Cooper |
| pamela.cooper@sa.gov.au | |
| Phone | 08 8222 6140 |
| Principal Investigator | Professor Tim Price |
| Recruitment Status | Recruiting |
| Hospital | Flinders Medical Centre |
|---|---|
| Clinical Trial Coordinator | Hannah Adelson |
| Hannah.adelson@sa.gov.au | |
| Phone | 08 8206 4835 |
| Principal Investigator | Professor Chris Karapetis |
| Recruitment Status | Recruiting |